litlas
ログインアカウント作成

David Klatzmann

1984–2025 年に発表

別表記
DAVID KLATZMANN
152
論文数
26,414
被引用数
90
h 指数
140
i10 指数

被引用数

David Klatzmann の年別被引用数1984 年: 被引用 28 件1985 年: 被引用 89 件1986 年: 被引用 145 件1987 年: 被引用 170 件1988 年: 被引用 165 件1989 年: 被引用 124 件1990 年: 被引用 114 件1991 年: 被引用 89 件1992 年: 被引用 91 件1993 年: 被引用 59 件1994 年: 被引用 56 件1995 年: 被引用 58 件1996 年: 被引用 53 件1997 年: 被引用 53 件1998 年: 被引用 71 件1999 年: 被引用 75 件2000 年: 被引用 90 件2001 年: 被引用 63 件2002 年: 被引用 80 件2003 年: 被引用 102 件2004 年: 被引用 106 件2005 年: 被引用 136 件2006 年: 被引用 146 件2007 年: 被引用 186 件2008 年: 被引用 140 件2009 年: 被引用 140 件2010 年: 被引用 130 件2011 年: 被引用 164 件2012 年: 被引用 159 件2013 年: 被引用 154 件2014 年: 被引用 156 件2015 年: 被引用 185 件2016 年: 被引用 191 件2017 年: 被引用 178 件2018 年: 被引用 253 件2019 年: 被引用 653 件2020 年: 被引用 708 件2021 年: 被引用 742 件2022 年: 被引用 763 件2023 年: 被引用 561 件2024 年: 被引用 877 件2025 年: 被引用 484 件2026 年: 被引用 20 件

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 3,314 件、この内訳の 30.7%中国: 引用元論文 1,026 件、この内訳の 9.5%フランス: 引用元論文 848 件、この内訳の 7.9%イギリス: 引用元論文 711 件、この内訳の 6.6%ドイツ: 引用元論文 618 件、この内訳の 5.7%イタリア: 引用元論文 461 件、この内訳の 4.3%日本: 引用元論文 334 件、この内訳の 3.1%オランダ: 引用元論文 315 件、この内訳の 2.9%カナダ: 引用元論文 314 件、この内訳の 2.9%オーストラリア: 引用元論文 291 件、この内訳の 2.7%スウェーデン: 引用元論文 206 件、この内訳の 1.9%スペイン: 引用元論文 205 件、この内訳の 1.9%
0%30.7%その他 19.9%

機関

分野

  • Immunology and Microbiology42%
  • Medicine37%
  • Biochemistry, Genetics and Molecular Biology15.2%
  • Neuroscience2.7%
  • Environmental Science0.5%
  • Agricultural and Biological Sciences0.5%
  • その他2.1%

トピック

  • Immune Cell Function and Interaction9.5%
  • T-cell and B-cell Immunology8.2%
  • Immunotherapy and Immune Responses4.8%
  • HIV Research and Treatment4.4%
  • Cancer Immunotherapy and Biomarkers2.7%
  • Atherosclerosis and Cardiovascular Diseases2.2%
  • その他68.2%

共著者

全論文

検索で開く
  1. A microbiota-modulated checkpoint directs immunosuppressive intestinal T cells into cancers

    著者: Marine Fidelle, Conrad Rauber, Carolina Alves Costa Silva, Ai-Ling Tian, Imran Lahmar, Anne-Laure Mallard de La Varende, Liwei Zhao, Cassandra Thélémaque, Isabelle Lebhar, Meriem Messaoudene, Eugénie Pizzato, Roxanne Birebent, Maxime Descartes Mbogning Fonkou, Silvia Zoppi, Anna Reni, Cécile Dalban, Marion Leduc, Gladys Ferrere, Sylvère Durand, Pierre Ly, Aymeric Silvin, Kevin Mulder, Charles‐Antoine Dutertre, Florent Ginhoux, Satoru Yonekura, María Paula Roberti, Maryam Tidjani Alou, Safae Terrisse, Jianzhou Chen, Oliver Kepp, Angela Schippers, Norbert Wagner, Javier Suárez-Gosálvez, Sebastian Kobold, Jean‐Eudes Fahrner, Corentin Richard, Jacques Bosq, Leonardo Lordello, Giacomo Vitali, Nathalie Galleron, Benoît Quinquis, Emmanuelle Le Chatelier, Lucas Blanchard, Jean‐Philippe Girard, Anne Jarry, Nadine Gervois, Emmanuelle Godefroy, Nathalie Labarrière, Ronald Koschny, Romain Daillère, Benjamin Besse, Caroline Truntzer, François Ghiringhelli, Nicolas Coatnoan, Vanessa Mhanna, David Klatzmann, Damien Drubay, Laurence Albigès, Andrew Maltez Thomas, Nicola Segata, François‐Xavier Danlos, Aurélien Marabelle, Bertrand Routy, Lisa Derosa, Guido Kroemer, Laurence Zitvogel - Science 2023 被引用: 221

  2. Cross-reactivity between tumor MHC class I–restricted antigens and an enterococcal bacteriophage

    著者: Aurélie Fluckiger, Romain Daillère, Mohamed Sassi, Barbara S. Sixt, Peng Liu, Friedemann Loos, Corentin Richard, Catherine Rabu, Maryam Tidjani Alou, Anne‐Gaëlle Goubet, Fabien Lemaître, Gladys Ferrere, Lisa Derosa, Connie P.M. Duong, Meriem Messaoudene, Andréanne Gagné, Philippe Joubert, Luisa De Sordi, Laurent Debarbieux, Sylvain Simon, Clara‐Maria Scarlata, Maha Ayyoub, Belinda Palermo, Francesco Facciolo, Romain Boidot, Richard Wheeler, Ivo G. Boneca, Zsófia Sztupinszki, Krisztián Papp, István Csabai, Edoardo Pasolli, Nicola Segata, Carlos López-Otı́n, Zoltán Szállási, Fabrice André, Valerio Iebba, Valentin Quiniou, David Klatzmann, Jacques Bou Khalil, S. Khelaifia, Didier Raoult, Laurence Albigès, Bernard Escudier, Alexander Eggermont, Fathia Mami‐Chouaib, Paola Nisticò, François Ghiringhelli, Bertrand Routy, Nathalie Labarrière, Vincent Cattoir, Guido Kroemer, Laurence Zitvogel - Science 2020 被引用: 384

  3. Abatacept/Ruxolitinib and Screening for Concomitant Respiratory Muscle Failure to Mitigate Fatality of Immune-Checkpoint Inhibitor Myocarditis

    著者: Joe‐Elie Salem, Marie Bretagne, Baptiste Abbar, Sarah Léonard-Louis, Stéphane Éderhy, Alban Redheuil, Samia Boussouar, Lee S. Nguyen, Adrien Procureur, Frederic Stein, Charlotte Fenioux, Perrine Devos, Paul Gougis, Martin Dres, Alexandre Demoule, Dimitri Psimaras, Timothée Lenglet, Thierry Maisonobe, Marc Pineton de Chambrun, Guillaume Hékimian, Christian Straus, Jésus Gonzalez‐Bermejo, David Klatzmann, Aude Rigolet, Perrine Guillaume-Jugnot, Nicolas Champtiaux, Olivier Benvéniste, Nicolas Weiss, Samir Saheb, Philippe Rouvier, Isabelle Plu, Estelle Gandjbakhch, Mathieu Kernéis, Nadjib Hammoudi, Noël Zahr, Claudia Llontop, Capucine Morélot‐Panzini, Lorenz Lehmann, Juan Qin, Javid J. Moslehi, Michèlle Rosenzwajg, Thomas Similowski, Yves Allenbach - Cancer Discovery 2023 被引用: 202

  4. The promise of low-dose interleukin-2 therapy for autoimmune and inflammatory diseases

    著者: David Klatzmann, Abul K. Abbas - Nature reviews. Immunology 2015 被引用: 619

  5. Natural regulatory T cells control the development of atherosclerosis in mice

    著者: Hafid Ait‐Oufella, Benoı̂t L. Salomon, Stéphane Potteaux, Anna-Karin L. Robertson, Pierre Gourdy, Joffrey Zoll, Régine Merval, Bruno Esposito, José L. Cohen, Sylvain Fisson, Richard A. Flavell, Göran K. Hansson, David Klatzmann, Alain Tedgui, Ziad Mallat - Nature Medicine 2006 被引用: 1,086

  6. Immunological and clinical effects of low-dose interleukin-2 across 11 autoimmune diseases in a single, open clinical trial

    著者: Michèlle Rosenzwajg, Roberta Lorenzon, P. Cacoub, Hang‐Phuong Pham, Fabien Pitoiset, Karim El Soufi, Claire Ribet, Claude C.A. Bernard, S. Aractingi, Beatrice Banneville, Laurent Beaugerie, Francis Bérenbaum, Julien Champey, Olivier Chazouillères, Christophe Corpechot, Bruno Fautrel, A. Mékinian, Elodie Régnier, David Saadoun, Joe‐Elie Salem, Jérémie Sellam, Philippe Seksik, Anne Daguenel-Nguyen, Valérie Doppler, Jéremie Mariau, Éric Vicaut, David Klatzmann - Annals of the Rheumatic Diseases 2018 被引用: 402

  7. Low-dose interleukin-2 therapy in active systemic lupus erythematosus (LUPIL-2): a multicentre, double-blind, randomised and placebo-controlled phase II trial

    著者: Jens Y. Humrich, P. Cacoub, Michèlle Rosenzwajg, Fabien Pitoiset, Hang Phuong Pham, Joel Guidoux, David Leroux, Thomas Vazquez, Gabriela Riemekasten, Josef S Smolen, George C. Tsokos, David Klatzmann - Annals of the Rheumatic Diseases 2022 被引用: 114

  8. Regulatory T cells in the treatment of disease

    著者: Amir Sharabi, Maria Tsokos, Ying Ding, Thomas R. Malek, David Klatzmann, George C. Tsokos - Nature Reviews Drug Discovery 2018 被引用: 295

  9. Interleukin-2 improves amyloid pathology, synaptic failure and memory in Alzheimer’s disease mice

    著者: Sandro Alves, Guillaume Churlaud, Mickaël Audrain, Kristin Michaelsen‐Preusse, Romain Fol, Benoît Souchet, Jérôme Braudeau, Martin Körte, David Klatzmann, Nathalie Cartier - Brain 2016 被引用: 176

  10. Low-dose interleukin 2 in patients with type 1 diabetes: a phase 1/2 randomised, double-blind, placebo-controlled trial

    著者: Agnès Hartemann, G. Bensimon, Christine Payan, Sophie Jacqueminet, Olivier Bourron, Nathalie Nicolas, Michèle Fonfrède, Michèlle Rosenzwajg, Claude C.A. Bernard, David Klatzmann - The Lancet Diabetes & Endocrinology 2013 被引用: 422

  11. Paracrine effect of regulatory T cells promotes cardiomyocyte proliferation during pregnancy and after myocardial infarction

    著者: Serena Zacchigna, Valentina Martinelli, Silvia Moimas, Andrea Colliva, Marco Anzini, Andrea Nordio, Alessia Costa, Michael Rehman, Simone Vodret, Cristina Pierro, Giulia Colussi, Lorena Zentilin, María Inés Gutiérrez, Ellen Dirkx, Carlin S. Long, Gianfranco Sinagra, David Klatzmann, Mauro Giacca - Nature Communications 2018 被引用: 202

  12. Regulatory T-Cell Responses to Low-Dose Interleukin-2 in HCV-Induced Vasculitis

    著者: David Saadoun, Michèlle Rosenzwajg, Florence Joly, Adrien Six, Fabrice Carrat, Vincent Thibault, D. Sène, P. Cacoub, David Klatzmann - New England Journal of Medicine 2011 被引用: 746

  13. Regulatory T-Cell Response to Low-Dose Interleukin-2 in Ischemic Heart Disease

    著者: Tian Zhao, Rouchelle Sriranjan, Zewen Kelvin Tuong, Yuning Lu, Andrew P. Sage, Meritxell Nus, Annette Hubsch, Fotini Kaloyirou, Evangelia Vamvaka, Joanna Helmy, Michalis Kostapanos, Navazh Jalaludeen, David Klatzmann, Alain Tedgui, James H.F. Rudd, Sarah J. Horton, Brian J.P. Huntly, Stephen P. Hoole, Simon P. Bond, Menna R. Clatworthy, Joseph Cheriyan, Ziad Mallat - NEJM Evidence 2021 被引用: 62

  14. Use of machine learning in osteoarthritis research: a systematic literature review

    著者: Marie Binvignat, Valentina Pedoia, Atul J. Butte, Karine Louati, David Klatzmann, Françis Berenbaum, Encarnita Mariotti‐Ferrandiz, Jérémie Sellam - RMD Open 2022 被引用: 83

  15. Low-dose IL-2 in children with recently diagnosed type 1 diabetes: a Phase I/II randomised, double-blind, placebo-controlled, dose-finding study

    著者: Michèlle Rosenzwajg, Randa Salet, Roberta Lorenzon, Nicolas Tchitchek, Alexandra Roux, Claude C.A. Bernard, Jean‐Claude Carel, Caroline Storey, Michel Polak, Jacques Beltrand, Chloé Amouyal, Agnès Hartemann, Pierre Corbeau, Éric Vicaut, Cecile Bibal, Pierre Bougnères, Tú-Anh Tran, David Klatzmann - Diabetologia 2020 被引用: 105

  16. Low-dose interleukin-2 fosters a dose-dependent regulatory T cell tuned milieu in T1D patients

    著者: Michèlle Rosenzwajg, Guillaume Churlaud, Roberto Mallone, Adrien Six, Nicolas Dérian, Wahiba Chaara, Roberta Lorenzon, S. Alice Long, Jane H. Buckner, Georgia Afonso, Hang‐Phuong Pham, Agnès Hartemann, Aixin Yu, Alberto Pugliese, Thomas R. Malek, David Klatzmann - Journal of Autoimmunity 2015 被引用: 249

  17. Immune checkpoint inhibitor-induced myositis, the earliest and most lethal complication among rheumatic and musculoskeletal toxicities

    著者: Yves Allenbach, C. Anquetil, Ali Manouchehri, Olivier Benvéniste, Olivier Lambotte, Bénédicte Lebrun‐Vignes, Jean‐Philippe Spano, Stéphane Éderhy, David Klatzmann, Michèlle Rosenzwajg, Bruno Fautrel, Jacquès Cadranel, Douglas B. Johnson, Javid J. Moslehi, Joe‐Elie Salem - Autoimmunity Reviews 2020 被引用: 141

  18. Estrogen-mediated downregulation of AIRE influences sexual dimorphism in autoimmune diseases

    著者: Nadine Dragin, Jacky Bismuth, Géraldine Cizeron-Clairac, Maria Grazia Biferi, Claire Berthault, Alain Serraf, Rémi Nottin, David Klatzmann, Ana Cumano, Martine Barkats, Rozen Le Panse, Sonia Berrih‐Aknin - Journal of Clinical Investigation 2016 被引用: 199

  19. Selective IL-2 Responsiveness of Regulatory T Cells Through Multiple Intrinsic Mechanisms Supports the Use of Low-Dose IL-2 Therapy in Type 1 Diabetes

    著者: Aixin Yu, Isaac Snowhite, Francesco Vendrame, Michèlle Rosenzwajg, David Klatzmann, Alberto Pugliese, Thomas R. Malek - Diabetes 2015 被引用: 207

  20. TGF-β and VEGF cooperatively control the immunotolerant tumor environment and the efficacy of cancer immunotherapies

    著者: Tristan Courau, Djamel Nehar-Belaid, Laura V. Flórez, Béatrice Levacher, Thomas Vazquez, Faustine Brimaud, Bertrand Bellier, David Klatzmann - JCI Insight 2016 被引用: 127

  21. Effect of Intracoronary Administration of AAV1/SERCA2a on Ventricular Remodelling in Patients with Advanced Systolic Heart Failure: Results from the Agent-Hf Randomized Phase 2 Trial

    著者: Jean‐Sébastien Hulot, Joe‐Elie Salem, Alban Redheuil, Jean‐Philippe Collet, S. Varnous, Patrick Jourdain, Damien Logeart, Estelle Gandjbakhch, Claude C.A. Bernard, Stéphane Hatem, Richard Isnard, Philippe Cluzel, Claude Le Feuvre, Pascal Leprince, Nadjib Hammoudi, François M. Lemoine, David Klatzmann, Éric Vicaut, Michel Komajda, Gilles Montalescot, Anne‐Marie Lompré, Roger J. Hajjar - European Journal of Heart Failure 2017 被引用: 112

  22. IL-2 reverses established type 1 diabetes in NOD mice by a local effect on pancreatic regulatory T cells

    著者: Yenkel Grinberg‐Bleyer, Audrey Baeyens, Sylvaine You, Rima Elhage, Gwladys Fourcade, Sylvie Grégoire, Nicolas Cagnard, Wassila Carpentier, Qizhi Tang, Jeffrey A. Bluestone, Lucienne Chatenoud, David Klatzmann, Benoı̂t L. Salomon, Eliane Piaggio - The Journal of Experimental Medicine 2010 被引用: 417

  23. T fr cells lack IL-2Rα but express decoy IL-1R2 and IL-1Ra and suppress the IL-1–dependent activation of T fh cells

    著者: Paul-Gydéon Ritvo, Guillame Churlaud, Valentin Quiniou, Laura V. Flórez, Faustine Brimaud, Gwladys Fourcade, Encarnita Mariotti‐Ferrandiz, David Klatzmann - Science Immunology 2017 被引用: 151

  24. Benchmarking of T cell receptor repertoire profiling methods reveals large systematic biases

    著者: Pierre Barennes, Valentin Quiniou, Mikhail Shugay, Evgeniy S. Egorov, Alexey N. Davydov, Dmitriy M. Chudakov, Imran Uddin, Mazlina Ismail, Theres Oakes, Benny Chain, Anne Eugster, Karl Kashofer, Peter P. Rainer, Samuel Darko, Amy Ransier, Daniel C. Douek, David Klatzmann, Encarnita Mariotti‐Ferrandiz - Nature Biotechnology 2020 被引用: 131